DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Genetic Disorder

Neurofibromatosis Type 1

MODERATE

An autosomal dominant disorder caused by NF1 gene mutations, characterized by multiple neurofibromas, café-au-lait spots, and learning disabilities. Increased risk of malignancies including malignant peripheral nerve sheath tumors.

Global Affected

2.5M

Countries

15

Symptoms

Café-au-lait spots
Neurofibromas
Lisch nodules (iris)
Learning disabilities
Scoliosis
Seizures
High blood pressure
Optic glioma

Treatment Options

Genetic counseling
Supportive care
Symptom management
Enzyme replacement (if applicable)
Physical therapy
Regular monitoring
Multidisciplinary care

Risk Factors

1Family history
2Genetic mutations
3Consanguinity
4Advanced paternal age
5Ethnic predisposition

Diagnostic Methods

  • 1Genetic testing
  • 2Clinical evaluation
  • 3Family history assessment
  • 4Specialized laboratory tests
  • 5Imaging studies
  • 6Biopsy (if applicable)

Prognosis

Variable. Most have normal lifespan. Malignant transformation in 3-5%. Learning disabilities common but manageable. Pain can be significant. MEK inhibitors transforming care for severe cases.

Prevention

  • Genetic counseling
  • Carrier screening
  • Prenatal diagnosis
  • Preimplantation genetic diagnosis
  • Family planning

Research Status

MEK inhibitors (selumetinib) for inoperable plexiform neurofibromas. Surgery for symptomatic tumors. Regular cancer surveillance. Multidisciplinary care for complications.

Sources

  • https://www.ncbi.nlm.nih.gov/books/NBK1116
  • https://medlineplus.gov/genetics
  • https://rarediseases.org

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.